Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial
Resource Type
Article
Authors
Kosiborod, Mikhail N ; Esterline, Russell ; Furtado, Remo H M ; Oscarsson, Jan ; Gasparyan, Samvel B ; Koch, Gary G ; Martinez, Felipe ; Mukhtar, Omar ; Verma, Subodh ; Chopra, Vijay ; Buenconsejo, Joan ; Langkilde, Anna Maria ; Ambery, Philip ; Tang, Fengming ; Gosch, Kensey ; Windsor, Sheryl L ; Akin, Emily E ; Soares, Ronaldo V P ; Moia, Diogo D F ; Aboudara, Matthew ; Hoffmann Filho, Conrado Roberto ; Feitosa, Audes D M ; Fonseca, Alberto ; Garla, Vishnu ; Gordon, Robert A ; Javaheri, Ali ; Jaeger, Cristiano P ; Leaes, Paulo E ; Nassif, Michael ; Pursley, Michael ; Silveira, Fabio Serra ; Barroso, Weimar Kunz Sebba ; Lazcano Soto, José Roberto ; Nigro Maia, Lilia ; Berwanger, Otavio
Source
In The Lancet Diabetes & Endocrinology September 2021 9(9):586-594
Subject
Primary Research Articles
Language
ISSN
2213-8587